Mutares SE & Co. KGaA (LON:0UTK)
28.70
-0.35 (-1.20%)
At close: Dec 12, 2025
Mutares SE & Co. KGaA Revenue
Mutares SE & Co. KGaA had revenue of 1.59B EUR in the quarter ending September 30, 2025, with 27.27% growth. This brings the company's revenue in the last twelve months to 6.15B, up 18.01% year-over-year. In the year 2024, Mutares SE & Co. KGaA had annual revenue of 5.32B with 12.63% growth.
Revenue (ttm)
6.15B EUR
Revenue Growth
+18.01%
P/S Ratio
0.10
Revenue / Employee
212.18K EUR
Employees
29,000
Market Cap
540.36M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.32B | 596.70M | 12.63% |
| Dec 31, 2023 | 4.72B | 956.60M | 25.39% |
| Dec 31, 2022 | 3.77B | 1.25B | 49.64% |
| Dec 31, 2021 | 2.52B | 927.40M | 58.32% |
| Dec 31, 2020 | 1.59B | 569.60M | 55.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |